BB1.AX · BLINKLAB LIMITED
Australia · RS rating 52 · As of 2026-10-14
| Price | 0.62 AUD |
|---|---|
| 1-day change | +0.8% |
| RS rating (overall / 1M / 3M / 12M) | 52 / 40 / 67 / 68 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 26 / 22 / 22 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +43.3% |
| Market cap (USD) | $79.1M |